Diagnostic value of serum soluble interleukin-2 receptor (SIL- 2R) and acute phase proteins levels (APP) in community acquired pneumonia

A. M. V. Trailescu, O. I. Nicolaescu, F. Toparceanu (Bucharest, Romania)

Source: Annual Congress 2003 - Clinical aspects of community-acquired pneumonia
Session: Clinical aspects of community-acquired pneumonia
Session type: Thematic Poster Session
Number: 972
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. M. V. Trailescu, O. I. Nicolaescu, F. Toparceanu (Bucharest, Romania). Diagnostic value of serum soluble interleukin-2 receptor (SIL- 2R) and acute phase proteins levels (APP) in community acquired pneumonia. Eur Respir J 2003; 22: Suppl. 45, 972

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical value of soluble interleukine-2 receptor (sIL-2R) serum level examination in the pulmonary sarcoidosis (PS)
Source: Eur Respir J 2003; 22: Suppl. 45, 226s
Year: 2003

Evaluation of serum concentration of soluble interleukin-2 receptors (sIL-2R) in different respiratory tract diseases
Source: Annual Congress 2009 - Pleural and parenchymal diseases
Year: 2009

Triggering receptor expressed on myeloid cells (TREM)-1 and its soluble form (sTREM-1) as a diagnostic marker of bacterial lung infection
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008


C Reactive Protein (CRP), procalcitonin (PCT) and proadrenomedullin (Pro-ADM), as markers to discriminate bacterial, viral and mixed community acquired pneumonia (CAP)
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010


Diagnostic accuracy of lipopolysaccharide-binding protein (LBP), fibrinogen and C-reactive protein (CRP) in differentiating pneumonia from acute bronchitis in primary care
Source: Annual Congress 2008 - Wider aspects of managing respiratory disease in primary care
Year: 2008


Acute phase proteins (APP) and serum iron in patients (pts) with simple community-acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 805s
Year: 2006

Surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with community acquired pneumonia (CAP) during the treatment program
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014


Serum levels of soluble forms of intracellular adhesion molecules in patients with community acquired pneumonia
Source: Annual Congress 2008 - Airway infection and host defence
Year: 2008

The relationship between serum soluble interleukin-2 receptor levels and disease severity in sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 355s
Year: 2006

The diagnostic value of soluble death receptor 5 in ARDS
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019

The levels of osteoprotegerin (OPG), interleukin 18 (IL-18) and soluble interleukin 2 receptor (sIL-2R) in serum during chemotherapy of lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 318s
Year: 2004

Serum levels of thrombopoietin (TPO) in patients with thrombocytosis due to lung cancer and in essential throbocythaemia (ET)
Source: Eur Respir J 2001; 18: Suppl. 33, 234s
Year: 2001

The discriminatory value of procalcitonin (PCT) and C-reactive protein (CRP) levels in HIV-seropositive patients presenting with community acquired pneumonia (CAP) due to pulmonary tuberculosis (PTB) compared with patients with pneumococcal pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 241s
Year: 2004

Serum level of soluble interleukin-2 receptors (sIL-2R) during acute asthma exacerbation, and its relation to severity and response to bronchodilator therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 141s
Year: 2002

C-reactive protein (CRP), an early prognostic tool in community acquired pneumonia (CAP)
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009


Study of angiotensin-converting enzyme, serum amyloid A, soluble interleukin-2 receptor, lysozyme and KL-6 in serum as diagnostic markers in pulmonary sarcoidosis
Source: Annual Congress 2007 - Sarcoidosis: various aspects
Year: 2007


Early stage asymptomatic (HRCT detectable) patients with IPF showed augmented serum surfactant protein D (SP-D)
Source: Eur Respir J 2002; 20: Suppl. 38, 61s
Year: 2002

Increased shedding of low density lipoprotein receptor-related protein-1 (LRP-1) in patients with acute respiratory distress syndrome (ARDS) prevents cellular clearance of matrix metalloproteinase-2 (MMP-2) and correlates with disease severity
Source: Annual Congress 2009 - Acute lung injury: biological mechanisms
Year: 2009


Relationship between interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha), C-reaktive protein (CRP), albumin (ALB) and alkaline phosphatase (ALP) in bronchoalveolar lavage fluid (BALF) of patients with interstitial lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 98s
Year: 2006

COPD: Acute exacerbation (AE) and hospitalization rate (HR) in patients with different serum surfactant protein D (SPD) level
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012